Monday, 27 March 2017

FDA approves Tesaro's ovarian cancer drug

(Reuters) - The U.S. Food and Drug Administration on Monday approved Tesaro Inc's drug, niraparib, for the treatment of recurrent ovarian cancer.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)